In the United States, the safety of cosmetic products is a complex area involving both governmental oversight and industry-led initiatives. The Food and Drug Administration (FDA) holds the primary responsibility for public safety concerning cosmetic products, operating under the framework of the Food, Drug, and Cosmetic Act. This act defines cosmetics broadly as "articles intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise
applied to the human body…for cleansing, beautifying, promoting attractiveness, or altering appearance." However, the FDA's authority in this domain has specific limitations, particularly regarding premarket approval and the mandatory submission of safety data by manufacturers. This regulatory environment highlights the importance of understanding how cosmetic ingredients are evaluated and the potential risks associated with certain chemicals.
The FDA's Role and Its Limitations
The FDA's regulatory power over cosmetics in the U.S. is not as extensive as it is for drugs. For instance, the FDA does not mandate premarket approval for most cosmetic ingredients or products, with the notable exception of color additives. This means that, for the vast majority of cosmetic products, manufacturers are not required to seek FDA approval before bringing them to market. Furthermore, the FDA is not legally responsible for ensuring cosmetic product or ingredient safety and does not possess the authority to compel manufacturers to submit their safety data. Instead, the legal responsibility for the safety of cosmetic products and their ingredients rests squarely with the cosmetic manufacturer. This framework places a significant burden on consumers to be informed and on manufacturers to ensure the safety of their offerings.
The Cosmetic Ingredient Review and Its Scope
Within this regulatory landscape, the Cosmetic Ingredient Review (CIR) plays a role in assessing cosmetic ingredient safety. Established in 1976 with support from the FDA and the Consumer Federation of America, the CIR utilizes an "Expert Panel" to review available data on cosmetic ingredients. Its purpose is to determine whether chemical ingredients in cosmetic products are safe for use, considering their current applications. However, the scope of the CIR's reviews is limited. An investigation by the Environmental Working Group revealed that only 11% of more than 10,000 cosmetic ingredients documented by the FDA had undergone a CIR review. This indicates that a large proportion of cosmetic ingredients on the market have not been subject to this expert panel's evaluation.
Chemical Concerns and Reproductive Risks
Research has shown that toxicological considerations are increasingly important in product formulation, yet reproductive risks are not always taken into account. With more than 9,000 chemicals found in cosmetic products, concerns about chemical exposures are significant, particularly for professionals like hairdressers who use a wide range of products. Hair dyes, for example, represent the largest segment of chemical products in the hair market and are a primary source of chemical exposure for hairdressers. The CIR itself, in 2002, deemed it safe for the industry to continue adding phthalates, known as possible endocrine and reproductive disruptors, to cosmetics for women of childbearing age. However, federal law later banned certain phthalates in children's products, highlighting a potential disconnect between some industry assessments and broader public health concerns regarding specific chemical ingredients.
